Study of South African Dialysis Patients

Stopped Study was terminated due to slow enrolment with no reasonable expectation of attaining a meaningful sample size

Conditions

• Chronic Kidney Disease, Receiving Dialysis

Interventions

• DRUG: Aranesp

Sponsor

Amgen